Bonamour, Inc. (fka BONI)

[Forexer1]

This message was sent to me ......

BONI is my new pick




Good Afternoon Traders!


My newest pick, BONI, isn’t a beautiful play because it happens to be in the beauty industry. The company’s beauty is all in the numbers.


Here’s what I mean:


BONI is making waves in an industry that was worth nearly $300 billion last year and which is forecast to have CAGRs of more than 10% over the next few years.


The industry I am talking about is the exploding anti-aging industry and right now there’s no other small cap on WallStreet that can match BONI for either gain or growth potential.


The play is massively undervalued with huge upside potential and recent trading has hinted at a potential breakout.


After a monstrous climb to .53 cents there has been a healthy pullback. This I believe is your entry opportunity because momentum, interest and volume are all bursting open.


As you read this market valuation is on the cusp of passing the second resistance point so I’d say the chances of BONI popping are incredibly strong.


Start your research now – reap the benefits shortly after.



Investor Highlights

BONI looks poised to breach its second resistance point of .2666. Current momentum is creating a groundswell of interest in the play.


BONI recently announced the retention of Blue C Advertising of Costa Mesa, California. This is huge and helps the company stay in the company of fellow Blue C companies including Monster Energy, Mini Cooper and Audiofly.


BONI has a RSI of 61 which is excellent positioning for an upward push.


BONI announced recently that it has received its Certificate of Free Sale issued by the Personal Care Products Counsel confirming that Bonamour products comply with all applicable state and federal guidelines in the United States of America. This is a huge catalyst.


BONI’s short term upward pressure is very strong. 5-day MA is up 42% while the 20-day MA is up 51%.


BONI has added more than 126% to lower valuations since January 2014. The strong gains have contributed to the very bullish technical chart currently in place.




About BONI

BONI (Bonamour, Inc.) develops high-end anti-aging skin care products, often referred to as cosmeceuticals.


BONI products are marketed and sold through its sales arm, Bonamour International, LLC. Bonamour International is focused on building a network marketing and direct sales/distribution organization for the Bonamour brand in Asia.


BONI target markets are comprised of nearly three billion people, many of whom are experiencing rapidly rising personal incomes and a strong affinity for U.S. made luxury goods.


BONI was founded in 2002 and is based in Dallas, Texas




Anti-aging Driving Boom in Cosmeceuticals Industry ($274 Billion in 2013)


The global market for anti-aging products and services was worth $162 billion in 2008, according to BCC Research. This will increase to $274.5 billion in 2013, for a compound annual growth rate (CAGR) of 11%.


The market is broken down into segments for disease, appearance and fitness. The disease treatment segment currently maintains the largest share of the market, worth $66 billion in 2008. This should increase at a CAGR of 12.5% to reach $119 billion in 2013. It consists of preventive and reactive healthcare for all the diseases of aging such as joint and bone health, Alzheimer's, sexual dysfunction, metabolic disorders, and eye and cardiovascular diseases (BCC Research, 2009).


The appearance segment possesses the second largest share of the market, worth more than $64 billion in 2008; it is expected to generate more than $105 billion by 2013, representing a CAGR of 10%. Facial rejuvenation, skin rejuvenation, hair care and body shaping products are the main components of this market (Datamonitor, 2009).


The fitness segment has the third largest market share and was worth almost $32 billion in 2008. The fitness market consists of bioregenerative, gym, spa and massage services, and is expected to reach nearly $50 billion in 2013, for a CAGR of almost 10% (Datamonitor, 2009).


There is some overlap, however. For example, some products cover more than two segments, such as facial care, skin care, hair care, drugs, supplements, nutraceuticals, complementary and alternative medicine therapies, and cosmetic and fitness equipment.


The services sector makes up a major portion of the global anti-aging market, accounting for more than 54% in 2008; its share will increase to 56% in 2013, for a CAGR of almost 12%. The products market will increase from $73 billion in 2008 to almost $200 billion in 2013, for a CAGR of more than 10% (Datamonitor, 2009).


It is estimated that the European cosmeceuticals market will be worth more than $4 billion in 2009, up 5% from 2008. In Europe, France and Germany follow behind the U.S. in their demand for drug-based beauty products, with sales turnover of nourishers/anti-aging products in 2007 at $1.2 billion and $1.1 billion, respectively (Kline Group, 2009).


In the U.S., the cosmeceutical market was worth $16 billion in 2007 and forecasts for 2012 put the market at $21 billion (Packaged Facts, 2009).
Meanwhile, Brazil, with its cultural emphasis on looks, has also experienced strong demand for anti-aging products, with annual sales of $927 million in 2007, up from $302 million in 2002 (Euromonitor International, 2009).


Although Japan maintains the largest skin care market globally, contrary to the rest of the world, spending on anti-aging products remains low, at less than 10%. This is compared to around 30% in the U.K. and U.S. In Japan and much of the Asia-Pacific market, cosmeceuticals are making inroads largely in the form of skin whitening and de-pigmentation products and powerful sunscreens.


Japan's lead in innovation and product development may suggest the evolving future of cosmeceuticals. For example, Japanese consumers have already embraced the concept of the "skinceutical," where beauty-enhancing products are added to food, such as Shiseido's Pure White skin whitening drink.


Also gaining ground, the Indian cosmeceuticals market is one of the fastest growing due to the increasing wealth among the middleclass. As a result, the Indian cosmetics and toiletries market has witnessed major changes both in terms of user perception and product availability during the past five years.
According to figures provided by the Confederation of Indian Industries (CII), the total Indian beauty and cosmetic market was valued at $950 million in 2008, exhibiting 15-20% growth per year. The overall beauty and wellness market, which includes beauty services, stands at about $2.7 billion, according to CII estimates.



Recent Developments

Bonamour Engages Award Winning Blue C Advertising for Product Branding
Bonamour, Inc., (BONI) announced today that it has retained Blue C Advertising of Costa Mesa, California. Blue C was retained to implement marketing and branding of the existing line of Bonamour anti-aging skincare products as well as branding for new product offerings from the Company. Blue C has an impressive client list including but not limited to Monster Energy(MNST), Toyota (TM), Mini Cooper, and Audiofly.

“We retained Blue C in December and have been working with them to enhance the branding of our existing product line and employ unique design elements for our new product concepts. We also look forward to working with the Blue C in conjunction with the launch of new products!” said Nathan Halsey CEO of Bonamour, Inc.

“We are happy to add our name to their list of high profile clients and excited to work with their talented and dedicated creative team,” added Halsey.


Bonamour Receives CFS Certification from the Personal Care Products Council for Export Registration for Singapore and Vietnam Markets

Bonamour, Inc., (BONI) announced today that the Company has received its Certificate of Free Sale issued by the Personal Care Products Counsel confirming that Bonamour products comply with all applicable state and federal guidelines in the United States of America. This certification is required by many Asian and European countries to facilitate the approval process for export of Bonamour products to such countries.

Bonamour, Inc. products are manufactured in compliance with all local and state laws and regulations and the Federal Food, Drug and Cosmetic Act, and, Bonamour, Inc. products are permitted to be sold in interstate commerce throughout the United States.

In the United States, such skin care products are legally classified as cosmetics, and the U.S. Food and Drug Administration (FDA) has not promulgated Good Manufacturing Practice regulations (GMP’s) for cosmetics. However, the Personal Care Products Council (formerly CTFA) has issued Technical Guidelines in the areas of quality assurance, microbiology, and pharmacology/toxicology, as guidance documents in lieu of formal cosmetic GMPs in keeping with the U.S. cosmetic industry’s commitment in the area of self-regulation.

“We enjoyed great success during the test launch of these products in Hong Kong selling over 4,000 sets of our Bonamour Rejuvenating Trio in the limited trial period. We are working diligently to open markets in Singapore and Vietnam as these countries have very similar consumer demographics to Hong Kong.” said Nathan Halsey, CEO of Bonamour, Inc.


BONI should be at the top of your trading list, and here’s why:


1. BONI’s presence in the mega anti-aging industry is a huge catalyst for trading interest, which is already taking place.


2. BONI’s near term momentum is pointing to one thing: breakout!


3. BONI is trading at a fraction of its intrinsic value. The 52-week high of .53 cents is a thin ceiling that could be shattered any moment now.


Don’t take your eyes off BONI; this play is on the cusp of a breakout.


To learn more about BONI please visit their website: http://www.bonamour.com/


Warm Regards,
Alexander Reeves
[e-mail]





IMPORTANT NOTICE AND DISCLAIMER:

The content of this e-mail is often paid advertising not a recommendation nor an offer to buy or sell securities. We are an information and marketing firm not a financial analyst, investment advisor or broker/dealer. We are in the business of marketing and advertising companies to generate exposure of them by sending alerts to our subscribers for monetary compensation and have been compensated thirty thousand for the dissemination of this report. Always do your own research and consult with a licensed investment professional before investing. This communication is never to be used as the basis of making investment decisions, and is for entertainment purposes only.

Investing in securities is highly speculative and carries a great deal of risk. You may lose your entire investment. If you cannot afford to lose your entire investment do NOT invest in securities. Frequently, companies profiled in our alerts may experience a large increase in volume and share price during the course of investor relations marketing, which may end as soon as the investor relations marketing ceases. The investor relations marketing may be as brief as one day, after which a large decrease in volume and share price is likely to occur.

We will never own or beneficially own any securities of any company mentioned in this email. We are advertisers, not investors or traders.




This message was sent to @gmail.com from:
Jens Henriksen | 905 W. 35th Street | Chicago, IL 60609
Email Marketing by

Unsubscribe | Forward To a Friend